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Blood Monocytes Consist of Two Principal Subsets
with Distinct Migratory Properties
cytes that develop in the BM from dividing monoblasts,
are released in the bloodstream as nondividing cells,
and enter tissues, where their fate remains largely a
Frederic Geissmann,1,3 Steffen Jung,1,3,4
and Dan R. Littman1,2,*
1Molecular Pathogenesis Program and the
topic for speculation (for review see Wiktor-Jedrzejczak2 Howard Hughes Medical Institute
and Gordon, 1996). With half of the circulating mono-Skirball Institute of Biomolecular Medicine
cytes leaving the bloodstream under steady-state con-New York University School of Medicine
ditions each day, monocytes could constitute a consid-540 First Avenue
erable systemic reservoir of myeloid precursors. ThisNew York, New York 10016
notion is supported by studies with cytokine-driven cul-
ture systems that allow in vitro differentiation of mono-
cytes into macrophages and their tissue-specific repre-Summary
sentatives as well as into DC (Akagawa et al., 1996;
Chapuis et al., 1997; Sallusto and Lanzavecchia, 1994;Peripheral blood monocytes are a heterogeneous pop-
Zhou and Tedder, 1996; Geissmann et al., 1998; Kiertscherulation of circulating leukocytes. Using a murine adop-
and Roth, 1996; Randolph et al., 1998; Schreurs et al.,tive transfer system to probe monocyte homing and
1999). However, experimental data on monocyte differ-differentiation in vivo, we identified two functional sub-
entiation and function in vivo are scarce, and the physio-sets among murine blood monocytes: a short-lived
logical role of this versatile cell type has only been in-CX3CR1loCCR2Gr1 subset that is actively recruited
ferred from histological and immunohistochemicalto inflamed tissues and a CX3CR1hiCCR2Gr1 subset
observations (Crofton et al., 1978; Randolph et al., 1999;characterized by CX3CR1-dependent recruitment to
Thomas et al., 1976; Wiktor-Jedrzejczak and Gordon,noninflamed tissues. Both subsets have the potential
1996).to differentiate into dendritic cells in vivo. The level of
Monocytes are defined as blood mononuclear cellsCX3CR1 expression also defines the two major human
with bean-shaped nuclei, expression of CD11b, CD11c,monocyte subsets, the CD14CD16 and CD14loCD16
and CD14 in humans and CD11b and F4/80 in mice, andmonocytes, which share phenotype and homing po-
lack of B, T, NK, and DC markers. However, in the sametential with the mouse subsets. These findings raise
way that cells originally described as lymphocytesthe potential for novel therapeutic strategies in inflam-
based on their appearance in peripheral blood smearsmatory diseases.
are now known to be comprised of many physiologically
distinct subsets, monocytes are morphologically and
Introduction phenotypically heterogeneous. The term monocyte may
therefore describe cells with overall similar appearance
The mononuclear phagocyte system (MPS) (van Furth, but different roles (Muller, 2001).
1988; Wiktor-Jedrzejczak and Gordon, 1996) is a spe- Mononuclear phagocytes, as represented by macro-
cialized tissue distributed throughout the body and com- phages and DC, are critical for both innate and adaptive
posed of strikingly diverse differentiated cell types. immunity. Interaction of antigen-specific T lymphocytes
These include liver Kupffer cells, lung alveolar macro- with antigen-presenting dendritic cells triggers the in-
phages, serosal (peritoneal) macrophages, brain micro- duction of adaptative immune responses and is also
glia, dendritic cells (DC), and osteoclasts, as well as likely to be critical for the control of tissue inflammation
granuloma-forming macrophages at sites of inflamma- and the maintenance of immune tolerance. As putative
tion (Wiktor-Jedrzejczak and Gordon, 1996). The MPS precursors for microglia and osteoclasts, monocytes
is of hematopoietic origin and is thought to require con- may also be involved in the physiology of the central
tinuous reconstitution. This could be achieved by self- nervous system and in bone remodeling. Understanding
renewal of differentiated cells (Lawson et al., 1992; of the role and fate of functional subsets of circulating
Merad et al., 2002), by proliferation of bone marrow monocytes in vivo is therefore an important and long-
(BM)-derived precursors in peripheral tissues (Martinez standing issue.
del Hoyo et al., 2002; Takahashi et al., 1996; Yamamoto To accurately study the fate of blood monocytes in
et al., 1996), or by the continuous extravasation and vivo, the experiment of choice is the adoptive transfer of
differentiation of circulating blood MPS precursors such marked blood monocytes into congenic recipient mice.
as blood monocytes or preimmunocytes (Bruno et al., However, the difficulty of isolating mouse monocytes,
2001; Kennedy and Abkowitz, 1998; Lagasse and Weiss- due to their relative rarity (Mouse Phenome Database,
man, 1997). These alternatives are not mutually exclu- http://aretha.jax.org/pub-cgi/phenome/mpdcgi?rtndocs/
home), their phenotypic heterogeneity, and their lack ofsive and might operate in parallel in the regeneration of
proliferation have in the past largely hampered transferthe individual MPS subsets.
experiments. Using adoptive transfer of GFP-labeledMonocytes are a population of mononuclear leuko-
monocytes, we report here that monocytes can be di-
vided into two main subsets: a short-lived “inflammatory*Correspondence: littman@saturn.med.nyu.edu
subset” that homes to inflamed tissue, where it can3 These authors contributed equally to this work.
trigger immune responses, and a “resident subset,” with4 Present address: The Weizmann Institute of Science, Department
of Immunology, Rehovot 76100, Israel. a longer half-life, that homes to noninflamed tissues.
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Figure 1. Definition of Mouse Monocyte Subsets by CX3CR1 Expression
(A) Blood mononuclear cells from CX3CR1gfp/RAG/ mice were stained for CD11b and I-A (left and middle panels) and FKN-Fc (right panel).
Binding of FKN-Fc is shown for gated populations of GFPlo cells (gray histogram) and GFPhi cells (black histogram).
(B) Blood mononuclear cells from CX3CR1gfp/RAG/ mice were stained for Ly6C/G (Gr1) and sorted, according to the indicated gates, for
microscopic analysis (middle panels). The arrows indicate red blood cells of 7 m diameter. The forward and side light scatter profiles of
GR1GFPhi (open histograms) and GR1GFPlo (filled histograms) cells are shown in the panels at right.
Accumulation of the “resident monocytes” in diverse cells) (Figure 1 and Table 1). The two monocyte subsets
were also characterized by the differential expressiontissues is facilitated by the expression of the chemokine
receptor CX3CR1. The dichotomy in monocyte subsets of a number of surface markers (Table 1). CX3CR1low
monocytes expressed CD62L (L-selectin), Ly6C/G (Gr1),has been conserved during evolution, as we have identi-
fied corresponding subsets in human blood. 2 and 4 integrin (VLA2, VLA4), LFA1, and CCR2, while
CX3CR1high cells expressed only LFA1 and VLA4.
Results CX3CR1 Expression Also Defines Two Major Human
Monocyte Subsets
CX3CR1 Expression Defines Two Subsets among To investigate whether differential CX3CR1 expression
Mouse Peripheral Blood Monocytes among monocyte subsets is conserved between ro-
In heterozygous CX3CR1GFP/ mice, one allele for the dents and primates, we stained human peripheral blood
gene encoding CX3CR1, the receptor for the membrane- cells with a Fkn-Fc fusion protein specific for CX3CR1.
tethered chemokine fractalkine (CX3CL1 or Fkn), has Several discrete CX3CR1 populations were identified
been replaced with the gene encoding green fluorescent among human leukocytes (Figure 2A). A population of
protein (GFP), which results in GFP labeling of all circu- DRCX3CR1 cells expressed CD2, CD16, and CD56
lating CD11b F4/80 cells (Jung et al., 2000; Palframan and corresponds to NK cells, as previously described
et al., 2001). GFP intensity and CX3CR1 surface expres- (Imai et al., 1997 and data not shown). A population
sion define two discrete subpopulations of monocytes of DRCX3CR1low cells (population 1 in Figure 2A) was
that are roughly equally represented in the blood of CD14hi, CD11bhi, CD11chi but was negative for T cell
CX3CR1GFP/ mice (Palframan et al., 2001; Figures 1A (CD2), B cell (CD19, CD24), interferon-producing cell
and 1B). CX3CR1lo monocytes are large granular mono- (IPC also called PDC or DC2) (BDC2A, CD123), and NK
nuclear cells of 10–14 m diameter, while CX3CR1hi cells cell (CD2, CD56) markers (Figure 2A, Supplemental Fig-
are smaller mononuclear cells with a diameter of 8–12 ure S1 at http://www.immunity.com/cgi/content/full/19/
m (Figure 1B). Both subsets were noncycling in the 1/71/DC1, and data not shown), and therefore corre-
blood (Ki67), expressed the hematopoietic antigens sponds to classical CD14 monocytes. These cells re-
CD45R0 and CD44, and lacked expression of lymphoid semble murine CX3CR1lowGr1 monocytes in that they
lineage markers, such as NK1.1 and DX5 (NK cells), have high forward and sideward scatter profiles and
CD90 (Thy1) and CD3 (T cells), CD19 and CD45R/B220 express CD62L (Figure 2A). A population of DR
CX3CR1high cells (population 2 in Figure 2A) was charac-(B cells), and MHC class II (I-Ab) and CD11c (dendritic
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fected in RAG-deficient mice (data not shown). GFP-Table 1. Phenotype of Mouse Monocyte Subsets
expressing monocytes were isolated from heparinized
Subset 1 Subset 2 blood of CX3CR1GFP/ RAG2/ C57BL/6 mice (CD45.2)
(Inflammatory) (Resident)
by Ficoll density gradient separation and depletion of
Monocyte marker MHC class II (I-Ab)- and CD11c-positive cells to exclude
CD11b   interferon-producing cells (IPC) and circulating DC.
F4/80   CX3CR1loGr1 and CX3CR1highGr1monocytes were thenLy6C/G  
fractionated by immunomagnetic sorting (SupplementalChemokine receptors
Figure S2), and 105 cells of each subset were separatelyCX3CR1 lo hi
CCR2   injected intravenously (IV) into nonirradiated C57BL/6
Adhesion molecules CD45.1 recipient mice. The allotypic CD45 marker rep-
CD31   resents an additional tool to identify the CD45.2 graft
LFA1   in CD45.1 hosts. The number of monocytes injected
VLA1  
(105) corresponded approximately to the total circulatingVLA2  
in a C57BL/6 mouse. Recipients of the monocyte trans-VLA4  
L-selectin (CD62L)   fer were bled and sacrificed at various time points and
Miscellaneous perfused to remove remaining cells from blood vessels.
CD16/32   Single-cell suspensions of various organs were pre-
CD44   pared by collagenase digestion and analyzed by flow
CD45  
cytometry for the presence of CD45.2/CD45.1GFPlow/hiCD45 RA, RB, RC  
donor-derived cells.KI67  
T, B, NK, IPC, DC markers Adoptively transferred CD45.2/CD45.1GFPhiGr1
CD90   cells were observed after transfer in the blood, spleen,
B220 (CD45R)   lung, liver, and brain of recipient mice, but not in
TCR   the lymph nodes, thymus, peritoneum, and broncho-
CD11c  
alveolar fluid (Figure 3A). In contrast, CD45.2/IA  (5%) 
CD45.1GFPlowGr1 cells were almost undetectable inNK1.1  
any tissue except spleen, as early as 1 day after transfer.
Similar results were obtained when Gr1 and Gr1
monocyte subsets were injected in the same mice or in
terized as being CD14lowCD16hi, CD11b, and CD11c separate mice.
but was negative for T, B, IPC, and NK cell markers. Monocytes are known to home to inflamed tissues
These cells correspond to the previously defined CD16 (van Furth, 1988). We therefore compared the homing
monocytes (Passlick et al., 1989) and resemble murine potential of the CX3CR1loGr1 and CX3CR1hiGr1 mono-
CX3CR1hiGr1 monocytes, as they are smaller and less cyte subsets during inflammation, using the model of
granular than the CX3CR1lowCD14 monocytes and do intraperitoneal (IP) thioglycollate injection (Lagasse and
not express CD62L (Figure 2A). Although both subsets Weissman, 1996). Upon transfer into an inflamed host,
expressed CXCR4, expression of inflammatory chemo- the ephemeral GFPlowGr1 monocytes invaded the peri-
kine receptors, including CCR1, CCR2, CXCR1, and toneum (Figures 3B and 3C). This finding is in accor-
CXCR2, was restricted to the CX3CR1low CD14 mono- dance with their expression of CD62L and CCR2, the
cytes (Figure 2B). We conclude that human monocytes, receptor for the proinflammatory chemokine MCP-1
although differing from mouse monocytes in terms of (Ajuebor et al., 1998; Boring et al., 1997; Kurihara et al.,
MHC class II and CD11c expression, can be divided into 1997; Lu et al., 1998; Palframan et al., 2001). In contrast,
two subsets that share size and granularity, as well as the migration pattern of the GFPhiGr1 monocyte subset
adhesion molecule and chemokine receptor expression appeared to be only slightly affected by inflammation, as
patterns, with the murine monocyte subsets. most of these cells were found in blood and noninflamed
peripheral organs (Figures 3B and 3C). Similar results
were obtained when Gr1 and Gr1 monocyte subsetsCX3CR1loGr1 and CX3CR1hiGr1 Monocytes
were injected in the same mice (Figure 3C) or in separateHave Distinct Homing Properties
mice (Figure 3B), indicating that Gr1GFPhi monocytesThe differential expression of adhesion molecules and
did not differentiate into Gr1GFPlow monocytes. Two tochemokine receptors by the two monocyte subsets in
five percent of both populations of grafted monocytesboth mice and humans prompted us to establish an
were recovered from recipients after these procedures.adoptive transfer system to compare their in vivo migra-
tion properties. Although monocytes represent less than
2% of peripheral blood mononuclear cells in wild-type CX3CR1loGr1 Monocytes Differentiate into Dendritic
Cells in Inflamed Tissues and TriggerC57BL/6 mice (Mouse Phenome Database, http://aretha.
jax.org/pub-cgi/phenome/mpdcgi?rtndocs/home), Naive T Cell Proliferation In Vivo
The adoptive monocyte transfer system allowed us tothey constitute, due to the absence of B and T lympho-
cytes, 45%–50% of leukocytes in RAG-deficient mice. study the differentiation potential of donor monocytes.
Before the adoptive transfer, both CX3CR1hiGr1 andTo facilitate isolation of monocytes, we therefore
crossed the CX3CR1GFP allele onto a lymphocyte-defi- CX3CR1loGr1 monocyte subsets are characterized by
the absence of the dendritic cell markers CD11c andcient C57BL/6 RAG2/ background. The phenotype of
monocytes, macrophages, and DC subsets is unaf- MHC class II (I-Ab) (Supplemental Figure S2). Both mono-
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Figure 2. CX3CR1 Expression on Two Distinct Human Monocyte Subsets
(A) Human peripheral blood mononuclear cells (PBMC) were stained with anti-HLA-DR, FKN-Fc, and one of the indicated antibodies. The
forward scatter profiles of gated populations 1 and 2 and expression of surface markers on these populations are shown at right and below,
respectively. Gate 3 corresponds to HLA-DRCD14CD16CD19BDCA2 cells (known as circulating DC or DC1), gate 4 corresponds to
CD16HLA-DR NK cells, and gate 5 contains CD19 B cells and IPC (see also Supplemental Figure S1 at http://www.immunity.com/cgi/
cont/full/19/1/71/DC1).
(B) PBMC were stained with FITC-conjugated anti-CD16, PerCp-conjugated anti-HLA-DR, APC-conjugated anti-CD14 antibodies, and FKN-Fc
followed by Cy3-conjugated goat anti-human IgG, or either one of PE-conjugated antibodies against CCR1, CCR2, CCR3, CCR4, CCR5, CCR6,
CCR7, CCR9, CXCR1, CXCR2, CXCR3, CXCR4, CXCR5, CXCR6, and isotype controls. Chemokine receptor expression levels on gated CD14
and CD16 monocytes are shown below. Open green histograms represent isotype control staining, and filled histograms represent specific
staining. The red-filled histograms indicate significant expression above background, and blue-filled histograms indicate differences in relative
levels of expression between the monocyte populations.
cyte subsets gave rise to CD11c MHC class II den- thymic lymph nodes that drain the peritoneal cavity
(Supplemental Figure S3).dritic cells after in vitro culture with GM-CSF and IL-4
(data not shown). To investigate the potential of the Blood monocytes do not stain for Ki67, a sensitive
marker of cycling cells. The rapid acquisition of CD11ctransferred monocytes to differentiate into DC in vivo,
we analyzed recipient mice for the presence of CD45.1/ and I-A expression by the transferred monocytes is
therefore likely to be due to differentiation rather thanCD45.2GFPCD11c MHC class IIcells.
We first investigated the fate of CX3CR1low monocytes. to expansion of a CD11cI-A or I-A DC precursor. The
results suggest that CX3CR1low monocytes can differenti-Strikingly, 18 hr after IV transfer into a recipient with an
inflamed peritoneum, a major fraction of donor-derived ate into DC in vivo. However, DC are best defined by
their ability to stimulate antigen-specific naive T cellsCD45.2GFPlowGr1 monocytes that had entered the
peritoneum had differentiated to express CD11c and I-A (Jung et al., 2002; Mellman and Steinman, 2001). We
therefore examined whether a monocyte graft can re-(Figures 3C and 3D). Some CD45.2GFPlowMHC class II
(I-Ab) cells were also observed in peripheral blood (Fig- constitute priming of naive CD8 T cells in a MHC class
I-deficient host. To this end, we injected MHC classures 3C and 3D). After 2 days, CD45.2GFPlowCD11c cells
were rare in the peritoneum and were absent from blood I-deficient recipient mice (2m/, CD45.1) intravenously
with CFSE-labeled CD8 T cells from mice expressingand inguinal lymph nodes, but were detected in para-
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an ovalbumin-specific transgenic TCR (106 naive were markedly reduced in recipient blood and tissues in
comparison to CX3CR1/GFP (GFPCD45.1) monocytesCD45.2 OT-I CD8 T cells [Hogquist et al., 1994]). The
mice then received an IP injection of thioglycollate and (Figure 5B and Table 2). The ratio of cotransferred
CX3CR1/GFP and CX3CR1GFP/GFP NK cells remained con-were grafted intravenously with monocytes (105 cells,
depleted of I-A/CD11c cells). Six hours after mono- stant (1:1) and thus served as an internal control. While
CX3CR1 deficiency affected homing of CX3CR1highGr1cyte transfer, recipient mice received an IP injection
of OVA peptide (50 g SIINFEKL). As expected, OVA monocytes, CX3CR1lowGr1 monocytes entered the in-
flamed peritoneum of recipients irrespective of theirpeptide-induced CD8 T cell proliferation, which was
readily observed in wild-type recipients, was impaired CX3CR1 genotype (Figure 5C).
in the MHC class I-deficient host. However, the adoptive
monocyte graft was able to partially restore antigen- Discussion
specific proliferation of class I-restricted T cells in lymph
nodes draining the peritoneum of the class I-deficient During the past several decades, lymphocytes have
host (Figure 3E). These results strongly suggest that been progressively subdivided into a growing number
CX3CR1lowGr1 monocytes, which acquire DC markers of phenotypically discrete subsets bearing distinct func-
in inflamed peritoneum, differentiate into functional DC, tions. Careful examination of the functions of these sub-
which have the ability to stimulate naive T cells. A frac- sets and the regulation of their differentiation has been
tion (25%) of CD45.2GFPCX3CR1high grafted cells also instrumental toward our current understanding of adap-
expressed CD11c and MHC class II (I-Ab) in the spleen tive immune responses and is contributing to the devel-
in the absence of inflammation 2 days after transfer (see opment of diagnostic and therapeutic tools for many
Figure 4A), suggesting that some CX3CR1high monocytes diseases. In contrast, there has been relatively little ef-
can acquire a DC phenotype in vivo. However, additional fort until recently to characterize cells involved in innate
studies will be required to confirm that the Gr1 mono- immune responses, particularly cells of the myeloid lin-
cyte subset can differentiate into functional DC. eages. In the last few years, there has been a growing
appreciation that dendritic cells, the specialized anti-
Entry of CX3CR1hiGr1 Monocytes into Uninflamed gen-presenting cells that link innate and adaptive im-
Tissues Is Sensitive to Pertussis Toxin mune responses, can be subdivided into at least two
It is well established that monocytes can be recruited functionally distinct subsets, the CD11c DC and the
to inflamed tissues by chemokines that bind to CCR2 interferon-producing cells (IPC, also called plasmacy-
and/or CXCR3 on their surface (Ajuebor et al., 1998; toid DC, or DC2 in human) (Cella et al., 1999; Siegal et
Boring et al., 1997; Janatpour et al., 2001; Kurihara et al., 1999). Cells of the mononuclear phagocyte system,
al., 1997; Lu et al., 1998; Palframan et al., 2001). including DC and macrophages, can be derived from
CD45.2CX3CR1high donor monocytes, which do not ex- cytokine-stimulated monocytes in vitro. However, it has
press CCR2, home to spleen, lung, liver, and brain of been difficult to demonstrate that these cells correspond
recipient mice in the absence of inflammation (Figure to the tissue-specific macrophages and DC that are
3A). Upon histological examination, GFP cells were found in vivo, and it has not been formally determined
found outside blood vessels in the marginal zone of the whether such cells differentiate from circulating mono-
spleen and beneath bronchial epithelium in the lungs of cytes that extravasate into tissues. In addition, although
mice that had received CX3CR1high monocytes (Fig- peripheral blood monocytes of human and mice had
ure 4B). been shown to be heterogeneous, functional subsets
Pretreatment of CX3CR1high monocytes with pertussis were not defined.
toxin, which inhibits Gi-mediated chemokine receptor In this study, we describe an adoptive monocyte
signaling (Cyster and Goodnow, 1995), prevented accu- transfer system that has allowed us to characterize two
mulation of grafted monocytes within recipient spleens major morphologically, phenotypically, and functionally
but did not affect their circulation in the blood of re- distinct subsets of circulating monocytes in the mouse.
cipient mice (Figure 4C). This finding suggests that Furthermore, we were able to identify putative human
CX3CR1high monocyte entry into tissues involves an ac- counterparts of these cells based on strikingly con-
tive mechanism, presumably engaging Gi-coupled che- served interspecies phenotypic similarities. A short-
mokine receptor(s). lived CX3CR1lowGr1 murine subset, which we term
“inflammatory monocytes,” represents immediate circu-
lating precursors for antigen-presenting DC and CD11cEngraftment of CX3CR1hiGr1 Monocytes
Is Dependent on CX3CR1 myeloid cells in inflammatory conditions. We have iden-
tified a second CX3CR1highGr1 monocyte subset thatFractalkine (CX3CL1), the ligand for CX3CR1, is a trans-
membrane chemokine that is expressed on endothelial persists longer in tissues and serves as a precursor for
resident myeloid cells, including CD11cI-A DCs, incells and can promote adhesion of monocytes (Bazan
et al., 1997; Fong et al., 1998; Goda et al., 2000). To noninflamed tissues including liver, lung, brain, and
spleen (Figure 6).investigate a potential role for CX3CR1 in the migration
of monocytes, we performed transfer experiments with We show that CX3CR1 expression also defines the
two main subsets of monocytes in human. Previouslya 1:1 mixture of heterozygous CX3CR1/GFP (CD45.1/
CD45.2) and homozygous mutant CX3CR1GFP/GFP described human CD16 monocytes (Passlick et al.,
1989; Ziegler-Heitbrock, 2000), whose in vivo role re-(CD45.2/CD45.2) monocytes into untreated CD45.1/
CD45.1 recipient mice (Figure 5A). After transfer of mains enigmatic, share many features with mouse
CX3CR1high monocytes. They are smaller in size and lessCX3CR1high cells, CX3CR1GFP/GFP (GFPCD45.1) cells
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Figure 3. Migration and Differentiation Properties of Monocyte Subsets
(A) Recruitment of monocyte subsets to tissues in the absence of inflammation. 1  105 purified monocytes of each subset were injected
intravenously (IV) into nonirradiated CD45.1 C57BL/6 recipient mice. At the indicated time points, recipient mice were analyzed for the
presence of GFPCD45.2NK1.1 cells in each organ. Results are representative of six independent experiments. In each experiment,
nongrafted CD45.1 C57BL/6 mice were used as staining controls (data not shown). Similar results were obtained when monocyte subsets
were injected separately (as shown here) or coinjected. Coinjected cells were distinguished from each other by the intensity of the GFP signal.
nd, not detected.
(B) Recruitment of monocyte subsets to inflamed tissue. Peritonitis was induced in recipient CD45.1 C57BL/6 mice by intraperitoneal injection
of 1 ml thioglycollate. Six hours later, 1  105 CX3CR1lowGr1 and 1  105 CX3CR1highGr1 monocytes were injected IV into separate recipients.
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granular than the CD14 monocytes, express a high thelium, and neurons. We have previously failed to dem-
onstrate a function for CX3CR1 in models of toxoplasma-level of CX3CR1, and are negative for CCR2 and L-selec-
tin. Human CD16 monocytes also lack expression of induced inflammation and microglial response to nerve
damage (Jung et al., 2000). We have demonstrated hereCCR1, CXCR1, and CXCR2, receptors for inflammatory
chemokines. This observation suggests that, like murine a function for this chemokine receptor, since we show
that CX3CR1 has a key role in the engraftment ofCX3CR1highGr1 cells, the CD16 monocytes are ex-
cluded from inflamed tissues. Interestingly, CD16 CX3CR1highGr1monocytes. Membrane bound or soluble
fractalkine encountered by CX3CR1highGr1 monocytesmonocytes have been shown to transmigrate through a
layer of resting endothelial cells in vitro more efficiently within blood vessels may provide adhesive and/or che-
motactic functions to enhance migration of monocytesthan CD14 monocytes (Randolph et al., 2002). This is
compatible with a shared potential of human and mouse into noninflamed tissues. This interpretation is sup-
ported by the recent report showing that the corre-CX3CR1high monocytes to give rise to resident tissue
cells, including DC. Of note, human CD14 and CD16 sponding human CD16 monocytes are better suited
than CD14 monocytes to migrate across endothelialmonocyte subsets can both give rise to DC in vitro (Sal-
lusto and Lanzavecchia, 1994; Sanchez-Torres et al., monolayers (Randolph et al., 2002). Binding of fractal-
kine to its receptor may also deliver a survival signal to2001). Accordingly, both murine monocyte subsets were
able to give rise to CD11cMHC class II dendritic cells CX3CR1highGr1 monocytes, as suggested by the obser-
vation that, in the absence of CX3CR1, these cells failin vitro after culture with GM-CSF and IL-4 (data not
shown). The monocyte subsets described here are dis- to persist in the blood (Table 2). A role for CX3CR1 signal-
ing in preventing monocyte apoptosis is supported bytinct from interferon-producing cells, which are
CX3CR1 in human (see Table 1 and Supplemental Fig- previous reports that CX3CL1 provides survival signals
for CX3CR1 microglia as well as human intestinal epi-ure S1 at http://www.immunity.com/cgi/content/full/19/
1/71/DC1), and have been described as B220, CD11c thelial cells (Boehme et al., 2000; Brand et al., 2002).
Moreover, other chemokine receptors, particularlyin mice (Asselin-Paturel et al., 2001).
We also identified an additional human mononuclear CXCR4, have been shown to couple to the antiapoptotic
Akt/PKB signaling pathway (Tilton et al., 2000). It willcell subset, expressing intermediate levels of CX3CR1
and representing about 1% of PBMC (gate 3 in Figure be interesting to investigate whether or not resident
monocytes can be further divided into subsets that2A). These cells are CD14CD16CD11cDRhigh (data
not shown) and correspond to circulating DC. Interest- home to distinct sites, e.g., skin, bone, lung, or brain,
as has been demonstrated for subsets of memory lym-ingly, in C57BL/6 mice maintained under SPF condi-
tions, the murine counterpart of this population is ex- phocytes.
Information about monocyte subsets and their func-ceedingly rare (I-A cells, see Figure 1A). However,
GFPCX3CR1lowI-A cells do appear in the blood of mice tions may impact our understanding of diseases and
the design of therapeutic strategies. CCR2CX3CR1highthat have received a CX3CR1low monocyte graft and an
IP injection of thioglycollate (Figure 3D). This suggests monocytes that home constitutively to tissues appear
to belong to a different group than CCR2CX3CR1lowthat monocytes can develop into cells with the features
of blood DC in animals that have ongoing tissue inflam- monocytes that home only when the tissue is inflamed.
The two subsets of monocytes may exhibit differentmation.
The chemokine receptor CX3CR1 has been shown in responses to pathogen products, and it will hence be
interesting to determine whether they differ in expres-vitro to have two distinct functions upon interacting with
its only known ligand, CX3CL1 (fractalkine), a type 1 sion of lectins and Toll-like receptors. Moreover,
CCR2CX3CR1low monocytes are likely to be involved intransmembrane protein with a chemokine domain teth-
ered on a extended mucin-like stalk (Bazan et al., 1997; innate inflammatory responses, contributing to clearing
Listeria monocytogenes from infected spleen (SerbinaImai et al., 1997). It mediates adhesion to cells that
express cell surface fractalkine and triggers chemotaxis et al., 2003 [this issue of Immunity]), as well as in trig-
gering of the adaptive response toward pathogens. Inin response to soluble fractalkine released by enzymatic
cleavage. CX3CR1 is expressed on blood monocytes contrast, cells derived from resident CCR2CX3CR1high
monocytes may be involved in tissue homeostasis, asand NK cells, as well as a small subset of T lymphocytes,
while fractalkine is expressed on endothelial cells, epi- populations of resident macrophages include special-
Donor-derived monocytes in blood, peritoneal exudate (PEC), and lung were analyzed after 18 hr. Similar results were obtained when
CX3CR1lowGr1 and CX3CR1highGr1 cells were coinjected in the same recipients. Results are representative of three experiments.
(C) Recruitment of monocyte subsets in the absence or presence of inflammation. Analysis of control (no transfer) mice and recipient (transfer)
mice 1 day after IV transfer of unfractionated monocytes. In the upper panels, peritoneal inflammation was induced with thioglycollate injection
(TG). The lower panels are controls without inflammation (TG). Dot plots represent GFP and I-A levels on blood, lung, and peritoneal
leukocytes.
(D) Expression of I-A and CD11c on CD45.1NK1.1CX3CR1lo monocytes recovered from peritoneal exudates, blood, and lung 18 hr after IV
transfer.
(E) Flow cytometric analysis of transferred CFSE-labeled OT-I CD8CD45.2 T cells 60 hr after immunization of wild-type C57BL/6 (B6.SJL,
CD45.1) and MHC class I-deficient mice (2m/, CD45.1) with the antigenic SIINFEKL peptide. The monocyte graft consisted of 105
unfractionated blood monocytes, depleted of I-A and CD11c cells. Dot plots represent cells gated on CD8 and TCR V5 T cells. Note
that the CFSE-negative population represents host CD45.2V5CD8 T cells. Histograms represent cells gated according to CD8, V5, and
CD45.2 expression.
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Figure 4. CX3CR1hi Monocyte Entry into Noninflamed Tissues Is Sensitive to Pertussis Toxin
(A) Analysis by flow cytometry of the expression of CD11c and I-Ab on CD45.1, NK1.1 monocytes from a recipient spleen 2 days after
transfer of blood Gr1 (CX3CR1high) CD45.2 I-A CD11c monocytes from CX3CR1gfp/ mice. The analysis included the NK1.1 marker since
the donor mice contain low numbers of GFP-expressing NK cells that were not depleted in this experiment.
(B) Analysis by fluorescence microscopy of recipient spleen and lung 2 days after transfer of purified monocytes depleted of I-A, CD11c,
GR1, and NK1.1 cells. Sections are stained with DAPI (blue nuclear staining) and anti-caveolin-1 (red, endothelial cell staining). The arrows
indicate GFP cells. * indicates epithelial autofluorescence. In the spleen panel, the lower left figures are a magnification of the top left figure.
(C) Analysis by flow cytometry of the presence of CD45.1, GFP donor-derived cells 2 days after transfer of pertussis toxin (PTX)- or control
PBS-treated monocytes.
Migration of Monocyte Subsets
79
Figure 5. Engraftment of CX3CR1hiGr1 Monocytes Is Dependent on CX3CR1
(A) I-ACD11c blood monocytes and NK cells were isolated from RAG/CD45.2/CD45.2 CX3CR1/ and RAG/ CD45.1/CD45.2 CX3CR1/
mice. Monocyte counts were assessed by flow cytometry, and equal numbers of Gr1 and/or Gr1 cells from CX3CR1/ and CX3CR1/ mice
were transferred into CD45.1/CD45.1 recipients. For analysis of donor-derived cells in recipient mice, blood was obtained by cardiac puncture,
and the animals were then perfused with cold PBS and sacrificed. The indicated organs were removed and cells were prepared as described
in the Experimental Procedures. Cell suspensions were then stained with CD45.1-PE, CD45.2-PerCp, and NK1.1-APC antibodies for four-
color FACS analysis.
(B) CD45.1 recipients received monocytes depleted of GR1 cells IV and were analyzed 2 days after transfer.
(C) CD45.1 recipients were injected IP with thioglycollate, received unfractionated monocytes IV, and were analyzed 18 hr after transfer.
Experimental Proceduresized subsets, such as osteoclasts, Kupffer cells, and
microglia. In light of their apparently different physiologi-
Animalscal functions, defects in one or the other subset may
CX3CR1gfp/mice were generated in the laboratory (Jung et al., 2000)
therefore result in different types of diseases. By tar- and backcrossed for ten generations to C57BL/6 mice. RAG2/
geting molecules restricted to CCR2CX3CR1low mono- and B6.SJL-Ptprca Pep3b/BoyJ (CD45.1) mice were obtained from
Taconic (Germantown, NY), and OT-1 transgenic mice were ob-cytes, such as chemokine receptors, it may be possible
tained from Jackson Laboratories. All mice were bred and main-to regulate their function in inflammatory diseases, with-
tained in our specific pathogen-free animal facility according toout affecting the potential homeostatic role of
institutional guidelines, and experiments were done at 6–12 weeksCCR2CX3CR1high monocytes in the brain or in the bone. of age.
In summary, we have shown, through the use of an
adoptive transfer system, the existence of two major Adoptive Transfer of Monocytes
subsets of circulating monocytes in mice and their con- Blood monocytes from RAG2/ CX3CR1gfp/ CD45.2C57BL/6 mice
were separated from PMN on a Ficoll gradient and depleted of I-Aservation between rodents and primates, and have also
and CD11c cells by immunomagnetic cell depletion using MACSperformed an initial characterization of their migratory
technology (Miltenyi Biotec, Bergisch Gladbach, Germany). Ly6C/properties and immune functions. This report also dem-
G (Gr1) and Ly6C/G (Gr1) monocytes were then separated by
onstrates, in an in vivo system, that monocytes differen- MACS sorting. NK1.1 cells were depleted by MACS before injection
tiate into DC that can stimulate naive T cells. in some experiments (e.g., for histological analysis). Congenic
CD45.1 C57BL/6 recipient mice were injected IV with 105 Gr1 or
Gr1 monocytes or with 2  105 cells consisting of a 1:1 mix of
Gr1 and Gr1 monocytes. Inflammation was induced by injecting
Table 2. Ratio of CX3CR1//CX3CR1/ Cells after Transfer of Gr1 1 ml of a PBS solution containing 3% thioglycollate medium (Difco,
Monocytes Detroit, MI) into the peritoneal cavity of the mice 6 hr before transfer-
ring the monocytes. Peritoneal exudate cells (PEC) were harvestedTimea Blood Lung Spleen Liver Brain
by lavage with PBS containing 5 mM EDTA. At various time points,
18 hr .2 mice were anesthetized using a cocktail of Ketamine (50 mg/kg),
36 hr .4 .24 .4 .5 .3 Xylazine (10 mg/kg), and Acepromazine (1.7 mg/kg) IV, and perito-
60 hr .14 .3 .6 .6 .4 neal and broncho-alveolar lavage (BAL) was performed, and periph-
eral blood was obtained. To perform BAL, the trachea was surgicallya Input at time 0 was at a ratio of 1.0.
exposed and cannulated. The airways were lavaged three times
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Figure 6. Model for Functional Dichotomy of
Monocyte Subsets
Resident monocytes (CD16 in human) ex-
press high levels of CX3CR1 which, upon in-
teraction with fractalkine, facilitates extrava-
sation into tissues, where these cells give rise
to specialized cell types. Inflammatory mono-
cytes (CD14 in human) express lower levels
of CX3CR1 but have high levels of other re-
ceptors that respond to inflammatory chemo-
kines, resulting in migration of the cells to
sites of inflammation, where they subse-
quently differentiate into dendritic cells.
with 1 ml of Ca2- and Mg2-free PBS (Gibco), containing 0.05 mM DR) and PE-conjugated antibodies (anti-CD1a, -CD2. -CD3,
sodium EDTA, the BAL fluid was centrifuged, and the cells were -CD11b, -CD11c, -CD14, -CD16, -CD19, -CD24, -CD56, -CD123)
resuspended in ice-cold HBSS. The peritoneum was lavaged with obtained from Pharmingen (San Diego, CA), with anti-BDCA-2 (Mil-
10 ml of Ca2- and Mg2-free PBS with 0.05 mM sodium EDTA using tenyi Biotech), with anti-CCR1, -CCR2, -CCR3, -CCR4, -CCR5,
a 10 ml syringe and an 18 gauge needle. Blood (500 l) was obtained -CCR6, -CCR7, -CCR9, -CXCR1, -CXCR2, -CXCR3, -CXCR4,
by cardiac puncture and collected in heparin-containing tubes (150 -CXCR5, -CXCR6 antibodies (a generous gift from R&D), with PerCp-
UI). Mice were then perfused with 20 ml of cold PBS and sacrificed. conjugated anti-HLA-DR and APC-conjugated anti-CD14 (from BD
For FACS analysis, the indicated organs were then dissected and Pharmingen), and with FKN-Fc (a kind gift of Millenium Pharmaceuti-
removed, washed in PBS, sliced, and incubated with collagenase cals) followed by Cy5-conjugated goat anti-human IgG or a Cy3-
D (1 mg/ml in PBS) for 45 min at 37	C, and cells were recovered on conjugated goat anti-human IgG (Jackson ImmunoResearch).
a Percoll gradient. Mouse cell suspensions were incubated with anti-mouse Fc
RII/
III (2.4G2) for 10 min at 4	C in FACS medium and then stained
Adoptive Transfer of Antigen-Specific T Cells with the following anti-mouse antibodies from BD PharMingen: PE-
Ovalbumin-specific CTL precursors, expressing a transgenic TCR coupled antibodies specific for Ly6C/G (Gr1), Ly6C, VLA-1, VLA-2,
specific for the SIINFEKL peptide presented in the context of MHC VLA-4, CD31, NK1.1, DX.5, LFA-1, CD90, CD11b, CD11c, I-Ab, CD44,
class I Kb, were isolated from OT-1 mice (Hogquist et al., 1994). CD45.1, CD45.2, CD45RA, CD45 RB, CD45RC, and V5; biotinylated
T cells were isolated from spleens and LN and enriched by magnetic anti-F4/80 (Caltag), CD11b, CD11c, and V8.1/2; and APC-coupled
depletion of I-AbB220non-T cells and positive enrichment of CD8 antibodies against TCR, B220, Ly6C/G (Gr1), CD11b, and CD11c.
T cells (Miltenyi Biotech). Cells were labeled with the intracellular Cells were analyzed on a FACSCalibur cytometer or LSR cytometer
fluorescent dye carboxyfluorescein diacetate succimidyl ester (Becton Dickinson, Mountain View, CA) using CellQuest software
(CFSE; Molecular Probes, C-1157) by incubating them in the ab- (Becton Dickinson).
sence of serum for 8 min at RT at 107 cells/ml in 5 M CFSE. CFSE
loading was stopped by addition of an equal volume of cold FCS.
Cells were washed twice in complete RPMI medium. 106 clonotype-
Cytological Analysis
positive CD8 cells were injected in 200 l of PBS into the tail veins
Cells were stained with antibodies against Ly6C/G (Gr1) and sorted
of 2m/ or wild-type CD45.1 C57BL/6 recipient mice. Recipient
for expression of GFP and Gr1. GFPhighGR1 and GFPlowGR1 cells
mice received thioglycollate IP, followed by a monocyte graft (105
were then centrifuged onto glass slides by using a Cytospin (Shan-
cells IV, depleted of I-A/CD11c cells), and were immunized IP
don, Pittsburgh, PA), dried for 1 hr at room temperature, and stainedwith ovalbumin (SIINFEKL) peptide. After 60 hr, the lymph nodes
with May-Grunwald-Giemsa, or fixed in acetone for 10 min anddraining the peritoneum and control inguinal lymph nodes were
stained with an avidin-biotin-peroxidase method revealed by 3–39removed, and donor-derived T cells were analyzed for CFSE inten-
diaminobenzidine as chromogen (Vectasin ABC Kit, Vector, CA),sity by four-color flow cytometry after staining with CD45.2, CD8,
using antibody against Ki67 (BD Pharmingen).and TCR-V2 antibodies.
Pertussis-Toxin Treatment of Monocytes
Histological AnalysisBlood monocytes from RAG/CX3CR1gfp/ CD45.2 C57BL/6 mice
Organs were washed in PBS, sliced, and fixed for 45 min at 4	C inwere depleted of I-A and CD11c cells by immunomagnetic cell
4% paraformaldehyde. Organs were then washed with PBS anddepletion. Monocytes were washed and resuspended in RPMI with
incubated overnight at 4	C in 30% sucrose, washed again in PBS,10% fetal calf serum, 2 mM glutamine, 100 mg/ml streptomycin,
embedded in OCT, and frozen. Fifty micron thick sections wereand 100 U/ml penicillin, and incubated with pertussis toxin (Sigma,
analyzed by fluorescence microscopy after staining with a rabbitP 7208) at 100 ng/ml or solvent as a control for 1 hr at 37	C in 5%
polyclonal serum against Caveolin-1 (Transduction Laboratories)CO2. Washed cells were injected into CD45.1 C57BL/6 recipient
followed by Cy-3-conjugated goat anti-rabbit Ig (Jackson Immuno-mice.
Research) to visualize endothelial cells (Liu et al., 1999) and DAPI
to visualize the nuclei. Visual data were acquired with an AxioplanFlow Cytometry
2 fluorescent microscope (Carl Zeiss, Jena, Germany) equippedHuman PBMC were incubated with goat or human IgG for 10 min
with a Cooke Corporation SensiCam CCD camera using SlideBookat 4	C in Ca2/Mg2-free PBS with 0.5% BSA and 0.05% NaN3 (FACS
medium), and stained with FITC-conjugated (anti-CD16 or anti-HLA- software (Intelligent Imaging Corporation).
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